FDA Recall Terminated

Dimension Enzymatic Creatinine Flex reagent cartridge, DF270. The ECRE method is an in vitro diagnostic test for the quantitative measurement of creatinine in human serum, plasma, and urine on the clinical chemistry system. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for other urine analytes.

Recall: Z-0485-2009 · Initiated September 29, 2008

Recall

Recall Number
Z-0485-2009
Event Number
50075
Firm
Dade Behring, Inc.
FEI Number
2517506
Product Code
JFY
Status
Terminated
Root Cause
Component design/selection
Initiated
September 29, 2008
Posted
December 13, 2008
Terminated
March 27, 2009
Address
500 GBC Drive PO BOX 6101, Mailstop 514, Newark, DE, 19714-6101

Description

Dimension Enzymatic Creatinine Flex reagent cartridge, DF270. The ECRE method is an in vitro diagnostic test for the quantitative measurement of creatinine in human serum, plasma, and urine on the clinical chemistry system. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for other urine analytes.

Reason

Reagent may exhibit unflagged inaccurate patient sample results.

Action

The recalling firm telephoned all customers on 9/29/08 to inform them of the problem. Customers were issued a letter dated 9/29/08 (and a response form) with instructions. Customers were instructed to complete the response form and fax (302-631-7242) it to Siemens Healthcare Diagnostics. For questions or additional information, contact the Siemens Technical Solutions Center at 800-441-9250.

Distribution

Nationwide Distribution.

Quantity

12,773 cartons